Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
prismpharma.com

See what CB Insights has to offer

Founded Year

2004

Stage

Acquired | Acquired

Total Raised

$30.4M

Valuation

$0000 

About Prism Pharmaceuticals

Prism Pharmaceuticals is an acute care pharmaceutical company engaged in developing and commercializing cardiovascular injectable products.

Prism Pharmaceuticals Headquarter Location

1150 First Avenue Suite 1050

King Of Prussia, Pennsylvania, 19406,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Prism Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Prism Pharmaceuticals is included in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Prism Pharmaceuticals Patents

Prism Pharmaceuticals has filed 1 patent.

The 3 most popular patent topics include:

  • Diseases of liver
  • Glycoproteins
  • Hepatology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/6/2017

4/23/2019

Hepatology, Diseases of liver, Glycoproteins, Transcription factors, Inflammations

Grant

Application Date

6/6/2017

Grant Date

4/23/2019

Title

Related Topics

Hepatology, Diseases of liver, Glycoproteins, Transcription factors, Inflammations

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.